Hospital Accused of Omitting Potassium Test Result from Medical Bulletin

Hemoglobin A1c, commonly known as HbA1c or glycated hemoglobin, is a crucial blood test used to monitor long-term blood sugar control in people with diabetes. This test measures the percentage of hemoglobin proteins in red blood cells that have glucose molecules attached to them. Since red blood cells live for approximately three months, the HbA1c test provides an average picture of blood glucose levels over the past two to three months, making it more informative than daily blood sugar measurements that only show glucose levels at a specific moment.

The HbA1c test is primarily used to diagnose diabetes and prediabetes, as well as to monitor how well diabetes treatment plans are working. For people without diabetes, normal HbA1c levels are typically below 5.7 percent. A result between 5.7 and 6.4 percent indicates prediabetes, which means blood sugar levels are higher than normal but not yet high enough to be classified as diabetes. An HbA1c level of 6.5 percent or higher on two separate tests indicates diabetes. For individuals already diagnosed with diabetes, the American Diabetes Association generally recommends maintaining HbA1c levels below 7 percent to reduce the risk of diabetes-related complications, though target levels may vary based on individual circumstances.

The test procedure is straightforward and requires only a small blood sample, which can be collected at any time of day without fasting. Healthcare providers typically recommend testing HbA1c every three to six months for people with diabetes, though testing frequency may vary depending on the type of diabetes, treatment plan, and how well blood sugar levels are controlled. More frequent testing may be necessary when diabetes medications are changed or if blood sugar control is poor.

Several factors can affect HbA1c test results and should be considered when interpreting the findings. Conditions that affect red blood cell turnover, such as anemia, recent blood loss, blood transfusions, or certain hemoglobin variants, can lead to inaccurate results. Pregnancy, kidney disease, and liver disease may also influence HbA1c levels. In such cases, healthcare providers may use alternative tests or adjust their interpretation of results accordingly. Despite these limitations, the HbA1c test remains one of the most reliable and convenient tools for assessing long-term glucose control and guiding diabetes management decisions.